Venture Capital

Back in 1986, when Bill Gates was still making sales calls, he pitched my group at First Boston on why we should bet the farm on Windows. Despite the risk involved, we gave his fledgling startup the deal. This wasn’t because of his financial backers...

Venture capitalists are generally not thought of with great affection by most entrepreneurs, which should be no surprise given that venture capitalists turn entrepreneurs away far more often than they let open their checkbooks for them, and have at best ambiguous relationships with most of...

From one perspective, the life sciences industry — the biotechnology companies that develop drugs and treatments to combat disease and the biomedical firms that create medical devices — is a picture of expanding horizons and confidence, The New York Times’s James Flanigan writes. Young companies are...

Semba Biosciences Inc. has received a $250,000 Technology Venture Fund loan from the Wisconsin Department of Commerce for equipment and working capital to expand its capabilities into additional product lines and international distribution. ...

In the early days of the modern venture capital industry, way back in the 1950s, most venture capital funds were generalists. That is, while the specific experiences and skills of the managing partners no doubt influenced the kinds of deals that interested various funds,...

The University of Wisconsin System Board of Regents approved a plan Friday to overhaul the antiquated computer system that manages its employee payroll and benefits, for an amount that could reach $81.4 million. The project comes just a few years after the UW System abandoned another...

Smart, savvy and very possibly soon-to-be-rich women from across the county will descend on Madison at the end of September in a reality show you won't see on television. Springboard Enterprises, an organization that pairs women-led technology companies with investors, will hold a two day seminar...

Matt Storms interviewed Scott Button, Managing Director of Venture Investors, a venture capital firm in Madison, Wisconsin. In this audio podcast of their conversation, Scott elaborates on the stage and industry focus of Venture Investors and their Venture Igniter program. He also describes...

OnBioVC.com recently reported on the trends of international VC bioscience funding for the 2Q 2009 and found that there were 88 financings for 2Q09 versus 71 deals in 2Q08. The combined second quarter 2009 bioscience investment totaled approximately $1.7B, an increase of roughly $538.2M compared...